1. Web alert

   OriginalPaper 31 January 2008 Pages: 1 - 1

2. Clinical trials report

   • Michael Clearfield

   Report 31 January 2008 Pages: 5 - 10

3. Statins in the spectrum of neurologic disease

   • J. David Orr

   OriginalPaper 31 January 2008 Pages: 11 - 18

4. Recognizing and improving patient nonadherence to statin therapy

   • Humayun J. Chaudhry
   • Brian McDermott

   OriginalPaper 31 January 2008 Pages: 19 - 24

5. Does the addition of fibrates to statin therapy have a favorable risk to benefit ratio?

   • Eliot A. Brinton

   OriginalPaper 31 January 2008 Pages: 25 - 32

6. What is the evidence in favor of low-dose statin therapy in 2008?

   • Karol E. Watson

   OriginalPaper 31 January 2008 Pages: 33 - 38

7. Do statins reduce events in patients with metabolic syndrome?

   • Sarah P. Towne
   • Eddie Thara

   OriginalPaper 31 January 2008 Pages: 39 - 44

8. Pleiotropic effects: Should statins be considered an essential component in the treatment of dyslipidemia?

   • Maureen E. Mays
   • Carlos A. Dujovne

   OriginalPaper 31 January 2008 Pages: 45 - 52

9. Exenatide as a treatment for diabetes and obesity: Implications for cardiovascular risk reduction

   • Derek D. Mafong
   • Robert R. Henry

   OriginalPaper 31 January 2008 Pages: 55 - 60

10. HIV therapy, metabolic syndrome, and cardiovascular risk

    • Vivian Pao
    • Grace A. Lee
    • Carl Grunfeld

    OriginalPaper 31 January 2008 Pages: 61 - 70

11. Rimonabant: New data and emerging experience

    • Suzanne M. Wright
    • Carolien Dikkers
    • Louis J. Aronne

    OriginalPaper 31 January 2008 Pages: 71 - 78

12. New approaches to therapy with omega-3 fatty acids

    • Puneet Kakar
    • Timothy Watson
    • Gregory Y. H. Lip

    OriginalPaper 31 January 2008 Pages: 79 - 87

13. Liver X receptors as therapeutic targets in metabolism and atherosclerosis

    • Takashi Nomiyama
    • Dennis Bruemmer

    OriginalPaper 31 January 2008 Pages: 88 - 95